TIC Solutions, Inc. (NYSE: TIC) ("TIC Solutions" or the "Company"), a leading provider of critical asset integrity solutions ...

Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2025, and recent corporate updates.

Microsoft's .NET 10 release highlights AI integration through the new Microsoft Agent Framework and related extensions, ...

Get key insights from Insight Molecular Diagnostics' Q3 2025 earnings call—FDA progress, $1B market outlook, and innovations in transplant testing.

Q3 2025 Earnings Call Transcript November 4, 2025 Exagen Inc. misses on earnings expectations. Reported EPS is $-0.19 EPS, ...

Generated revenue of $35 million, driven by strong performance of the foundational PAC businessReported Adjusted EBITDA of $5.2 million, ...

During the exhibition, BV will highlight its comprehensive solutions under the three key pillars of net-zero transformation — New Energy, Sustainability, and Cybersecurity — demonstrating BV's strong ...

Clinical Data—SIMPLIFY Study -- Updated analysis increased Gallery's PPV in symptomatic patients to 84.2% after long-term ...

Adaptive Biotechnologies Corp (ADPT) reports a 102% revenue increase and improved financial guidance, showcasing robust ...

On the MRD Pharma segment, Robins reported revenue up 11% year-over-year including $6.5 million in milestone revenue and a backlog exceeding $200 million. The company remains confident in MRD's ...

Product Launch Pipeline -- 1.25-megawatt modular natural gas power platform set for launch by year-end 2025, targeting large ...